The underlying molecular mechanisms leading to anti-VE-cadherin autoantibodies production need to be clarified, comparing anti-VE-cadherin autoantibodies in patients with RA and vasculitis versus patients with RA without vasculitis. The gene discussed is CDH5; the disease is vasculitis.